TSX:CRONPharmaceuticals
Cronos Group (TSX:CRON) Is Up 6.4% After Swinging Back To Profit And Beating Q2 Expectations
Cronos Group Inc. recently reported its second-quarter 2026 results, with sales of US$70.6 million, revenue of US$53.01 million, and net income of US$32.09 million, reversing a net loss in the same period last year.
Over the first half of 2026, the company moved from a net loss to net income of US$45.84 million, with basic earnings per share from continuing operations improving from a loss of US$0.09 to earnings of US$0.12, while also beating consensus expectations on both revenue and...